Skip to main content
. 2020 Apr 10;9(1):1747332. doi: 10.1080/2162402X.2020.1747332

Figure 2.

Figure 2.

Tumor-infiltrating IL-17A+ cells and IL-17A mRNA indicate better survival for patients. (a and b) Kaplan–Meier curves comparing OS and RFS in muscle-invasive bladder cancer patients with high and low tumor-infiltrating IL-17A+ cells/IL-17A mRNA. (c and d) Multivariate cox regression analysis for IL17A expression and clinic-pathological variables.